ByCus will carry out business in pharmaceuticals, biopharmaceuticals, biotechnology, nutraceuticals, medical devices & diagnostics. We do Research & Development, technology development, contract research & manufacturing and commercial manufacturing in alone or in collaboration with public or/and private entities for producing pharmaceuticals, such as APIs, pharmaceutical intermediates, bulk drugs, small molecule entities; biopharmaceuticals such as peptides, proteins, heparins, enzymes from micro-organisms, body fluids/tissues of animal or human origin, and genetically modified organisms for therapeutic or diagnostic or research purposes. ByCus develop prototypes, working models, products, reagents, instruments, and services for medical devices, diagnostics, and laboratory research.

Research and development

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.